Application 205858
- Type
- NDA
- Sponsor
- GILEAD SCIENCES INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ZYDELIG | IDELALISIB | TABLET;ORAL | 100MG | Yes | No |
| 002 | ZYDELIG | IDELALISIB | TABLET;ORAL | 150MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 61958-1701 | Zydelig | idelalisib | Gilead Sciences, Inc. | NDA | Current |
| 61958-1701 | Zydelig | idelalisib | Gilead Sciences, Inc. | NDA | Current |
| 61958-1701 | Zydelig | idelalisib | Gilead Sciences, Inc. | NDA | Current |
| 61958-1702 | Zydelig | idelalisib | Gilead Sciences, Inc. | NDA | Current |
| 61958-1702 | Zydelig | idelalisib | Gilead Sciences, Inc. | NDA | Current |
| 61958-1702 | Zydelig | idelalisib | Gilead Sciences, Inc. | NDA | Current |